Page 115 - Read Online
P. 115

Page 2 of 14                                                 Santillan Hepatoma Res 2020;6:63  I  http://dx.doi.org/10.20517/2394-5079.2020.60

               Table 1. LI-RADS v2018 diagnostic categories
                Category                                             Definition
                LR-1                            Definitely benign
                LR-2                            Probably benign
                LR-3                            Intermediate probability of malignancy
                LR-4                            Probably HCC
                LR-5                            Definitely HCC
                LR-M                            Probably or definitely malignancy but not HCC specific
                LR-TIV                          Definite tumor in vein
                LR-NC                           Cannot be categorized due to image degradation or omission
               LI-RADS: Liver Imaging Reporting and Data System; HCC: hepatocellular carcinoma; LR-TIV: LI-RADS Tumor in Vein



























               Figure 1. LI-RADS Diagnostic Table. Reproduced with permission from the American College of Radiology LI-RADS version 2018 manual.
                                                                               [4]
               Available from: https//www.acr.org/Clinical-resources/Reporting-and-Data-Systems/LI-RADS . LI-RADS: Liver Imaging Reporting and
               Data System
               for the evaluation of contrast-enhanced ultrasound, screening ultrasound, and CT and MRI following
               locoregional therapy for HCC. LI-RADS v2018 also includes technical recommendations for the
               performance of CT and MRI for the evaluation of HCC. The development of LI-RADS has been in the
               context of patients with cirrhosis, chronic hepatitis B infection without cirrhosis, or a history of prior
               HCC. LI-RADS should not be used in patients with vascular causes for their cirrhosis due to the decreased
                                                                             [3]
               specificity of arterial hyperenhancement for malignancy in these patients .
               LI-RADS V2018
               The LI-RADS algorithm provides a step by step approach for consistent categorization of observations
               seen on CT and MR imaging of patients with cirrhosis, chronic hepatitis B viral infection, or a history
                      [4]
               of HCC . Observations that are definitely benign (LR-1) or probably benign (LR-2) can be categorized
               based on typical imaging features associated with specific benign entities, such as hepatic hemangiomas,
               cysts, or perfusion alterations. Observations that demonstrate imaging features suggestive of malignancies
               other than HCC are categorized as LR-M. These imaging features include peripheral washout appearance,
               targetoid restricted diffusion, and rim arterial phase hyperenhancement. Observations that are not initially
               categorized as LR-NC, LR-1, LR-2, LR-M, or LI-RADS Tumor in Vein (LR-TIV) are then categorized using
               the LI-RADS Diagnostic Table [Figure 1]. The diagnostic table guides the radiologist to category LR-3, LR-4,
               or LR-5 based on the presence or absence of major features as discussed in further detail below.
   110   111   112   113   114   115   116   117   118   119   120